Welcome to our dedicated page for Tenet Healthcare news (Ticker: THC), a resource for investors and traders seeking the latest updates and insights on Tenet Healthcare stock.
Tenet Healthcare Corporation reports developments across a diversified healthcare services business that combines ambulatory surgery, hospital operations and healthcare-services outsourcing. Its care delivery network includes United Surgical Partners International, which operates ambulatory surgery centers and surgical hospitals, along with acute care and specialty hospitals, outpatient facilities, employed physician networks and a global business center in Manila.
Recurring news themes for THC include quarterly earnings, financial outlooks, same-facility revenue trends, Ambulatory and Hospital segment performance, payer-mix and expense-management commentary, and capital or ownership actions involving Conifer Health Solutions. Company updates also cover Conifer's revenue cycle management and value-based care services for hospitals, health systems, physician practices, employers and other clients, as well as Tenet's presentations at healthcare investor conferences.
Tenet Healthcare (NYSE: THC) reported second quarter 2026 net operating revenues of $5.63 billion, up 6.8% year-over-year, and net income available to common shareholders of $826 million, or $9.84 per diluted share, versus $288 million, or $3.14, in 2025. Adjusted diluted EPS rose 52.2% to $6.12 and consolidated Adjusted EBITDA increased 16.3% to $1.304 billion with a 23.2% margin, exceeding prior guidance assumptions.
Ambulatory segment Adjusted EBITDA was $542 million, up 8.8%, with a 39.0% margin, while Hospital segment Adjusted EBITDA rose to $762 million, a 22.3% increase and 18.0% margin, aided by higher acuity and Medicaid supplemental revenues. The Board approved a $2.0 billion increase to the share repurchase program, leaving $2.13 billion authorized. Tenet raised its 2026 Outlook, now guiding to Adjusted EBITDA of $4.83–$5.03 billion and Adjusted free cash flow of $2.725–$3.025 billion.
Tenet Healthcare (NYSE:THC) will release its second quarter 2026 results before the market opens on Friday, July 24, 2026, followed by a conference call at 10:30 a.m. CT (11:30 a.m. ET). A live webcast and audio archive will be available via its investor relations website.
Tenet Healthcare (NYSE: THC) will present at the BofA Securities Health Care Conference on Wednesday, May 13, 2026 at 6:00 p.m. ET. A live webcast and audio archive will be available via Tenet's investor relations website, with a replay accessible for 30 days.
Tenet Healthcare (NYSE: THC) reported first quarter 2026 results: net income $702 million ($8.01 diluted), Adjusted diluted EPS $4.82 (up 10.6% YoY), and Consolidated Adjusted EBITDA $1.162 billion with a 21.6% margin. Net operating revenues were $5.368 billion. Free cash flow and adjusted free cash flow improved; FY 2026 Adjusted EBITDA outlook is $4.485–$4.785 billion.
Results reflect contributions from the CommonSpirit agreement (one-time revenue recognition), stronger ambulatory same-facility revenues, offset by unfavorable payer mix and lower exchange admissions in hospitals.
Tenet Healthcare (NYSE: THC) will report first quarter 2026 results before market open on Thursday, April 30, 2026, followed by a conference call at 9:00 a.m. CT (10:00 a.m. ET).
A live webcast and an audio archive will be available via Tenet's investor relations website at www.tenethealth.com/investors.
Tenet Healthcare (NYSE: THC) will present at the Barclays 28th Annual Global Healthcare Conference on Tuesday, March 10, 2026 at 9:30 a.m. ET.
A live webcast and audio archive will be available via the company's investor relations site, with a replay accessible for 30 days.
Tenet (NYSE: THC) reported strong Q4 2025 and full-year results, with Q4 net income $371M ($4.22/diluted share) and Adjusted EBITDA $1.183B. FY2025 free cash flow was $2.53B and net debt/Adjusted EBITDA improved to 2.25x. Tenet provided FY2026 guidance: Adjusted EBITDA $4.485B–$4.785B and diluted EPS $29.60–$32.27. Tenet announced a Jan 27, 2026 agreement with CommonSpirit delivering $1.9B in payments and recording ~$1.65B contract termination revenue in 2026.
Tenet Healthcare (NYSE: THC) completed a transaction with CommonSpirit to resume full ownership of Conifer Health Solutions effective January 1, 2026.
Key terms include approximately $1.9 billion in payments from CommonSpirit over three years, a $540 million redemption, a reduction in redeemable noncontrolling interest of ~$885 million, and an increase to additional paid-in capital of ~$305 million. Tenet estimates 2025 Adjusted EBITDA at the upper end of its $4.47–$4.57 billion guidance. Conifer will continue serving CommonSpirit through year-end 2026. A management webcast is scheduled for February 2, 2026.
Tenet Healthcare (NYSE: THC) will report its fourth quarter 2025 results before the market opens on Wednesday, February 11, 2026.
The company will hold a conference call at 9:00 a.m. CT (10:00 a.m. ET) the same day. A live webcast and audio archive will be available in the investor relations section at www.tenethealth.com/investors.
Ryder (NYSE: R) announced the election of Tammy Romo to its board of directors, effective January 5, 2026. Romo will serve on Ryder’s Audit and Finance Committees.
Romo retired as executive vice president and chief financial officer of Southwest Airlines on April 1, 2025 after more than 30 years with the company and a decade overseeing corporate financial functions. She has served as an independent director of Tenet Healthcare (NYSE: THC) since 2015.